Emcure Pharmaceuticals reports strong Q2FY25 with 20% revenue growth and 38% PAT growth

The company reported a 20.4 per cent year-on-year (y-o-y) increase in revenue, with total sales reaching ₹2,002 crore for Q2FY25.